Multicenter randomized trial of arsenic trioxide and Realgar‐Indigo naturalis formula in pediatric patients with acute promyelocytic leukemia: Interim results of the SCCLG‐APL clinical study

Intravenous arsenic trioxide (ATO) has been adopted as the first‐line treatment for acute promyelocytic leukemia (APL). Another arsenic compound named the Realgar‐Indigo naturalis formula (RIF), an oral traditional Chinese medicine containing As(4)S(4), has been shown to be highly effective in treat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Hematol
Autors principals: Yang, Ming‐Hua, Wan, Wu‐Qing, Luo, Jie‐Si, Zheng, Min‐Cui, Huang, Ke, Yang, Li‐Hua, Mai, Hui‐Rong, Li, Jian, Chen, Hui‐Qin, Sun, Xiao‐Fei, Liu, Ri‐Yang, Chen, Guo‐Hua, Feng, Xiaoqin, Ke, Zhi‐Yong, Li, Bin, Tang, Yan‐Lai, Huang, Li‐Bin, Luo, Xue‐Qun
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Inc. 2018
Matèries:
Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6282847/
https://ncbi.nlm.nih.gov/pubmed/30160789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.25271
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars